← Back to headlines
Novo Nordisk's New Weight Loss Drug Underperforms Rival in Trial
Novo Nordisk's new weight loss injection has not performed as well as a rival drug from Eli Lilly in a recent clinical trial, causing a drop in its stock.
23 Feb, 14:29 — 23 Feb, 14:29
ℹOnly 1 source covers this story
Related Stories
Dietitian Warns Against Habits Damaging Gut Health
2m ago
Newborn's Tragic Death in Alytus: Mother Claims She Was Sober and Fell Asleep While Feeding
11m ago
Fact-check: Tényleg áltudományos humbugokkal népszerűsített étrend-kiegészítőket árul Csézy férje?
11m ago
No evidence behind RFK Jr’s claim keto diet can cure schizophrenia, experts say
19m ago